EZH2: a molecular switch of the MPN phenotype

In this issue of Blood , [Yang et al][1] show the unexpected cooperation between enhancer of zeste homolog 2 ( Ezh2) deletion and Jak2 V617F, in switching the myeloproliferative neoplasm (MPN) phenotype in a mouse model. Their work also provides new therapeutic targets to block the progression of